Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

A New Class of Antiemetic Agents on the Horizon

Cynthia N. Rittenberg
CJON 2002, 6(2), 103-104 DOI: 10.1188/02.CJON.103-104

This article reviews a new class of antiemetic agents, the neurokinin-1 (NK-1) receptor antagonists (RAs). Clinical trials of an NK-1 RA, aprepitant, are ongoing.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or